D9Ertd402e Inhibitors
Chemical inhibitors of D9Ertd402e act through various mechanisms to modulate the activity of this protein. Staurosporine, a well-known protein kinase inhibitor, prevents the phosphorylation of D9Ertd402e by obstructing the action of kinases responsible for its activation. Similarly, LY294002 and Wortmannin serve as inhibitors of the PI3K/Akt pathway, resulting in a reduction of Akt-mediated phosphorylation signals that are essential for D9Ertd402e activation. Rapamycin specifically interacts with the mTOR pathway by binding to mTORC1, leading to a decrease in D9Ertd402e activity as mTOR is a key regulator in protein synthesis and cellular growth processes.
In addition to these, PD98059 and U0126 both target MEK1/2 in the MAPK pathway, hence preventing the activation of ERK, which is crucial for the phosphorylation and subsequent activation of D9Ertd402e. SB203580, by selectively inhibiting p38 MAP kinase, disrupts the stress response signaling that may involve D9Ertd402e. PP242, an mTOR inhibitor, attenuates the function of both mTORC1 and mTORC2 complexes, which in turn affects the activity of D9Ertd402e that lies downstream in the mTOR signaling pathway. SP600125's inhibition of JNK, another MAPK pathway constituent, can lead to reduced activity of D9Ertd402e if it is regulated by JNK-mediated signaling. Lastly, Dasatinib, Erlotinib, and Sorafenib are broad-spectrum kinase inhibitors that impede various kinases that phosphorylate D9Ertd402e, thereby influencing its activity. Dasatinib's broad-spectrum approach targets multiple tyrosine kinases, Erlotinib specifically inhibits EGFR tyrosine kinase, and Sorafenib acts on several receptors and kinases, all converging on the regulation of D9Ertd402e activity.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including those which phosphorylate D9Ertd402e. By inhibiting these kinases, Staurosporine prevents the phosphorylation of D9Ertd402e, thereby inhibiting its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of the PI3K/Akt pathway, which is known to regulate a variety of proteins including D9Ertd402e. Inhibition of PI3K leads to reduced phosphorylation and activation of Akt, which in turn leads to reduced activity of D9Ertd402e due to lack of necessary phosphorylation signals. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits the mTOR pathway by binding to mTORC1. Since mTOR is involved in the regulation of protein synthesis and cell growth, its inhibition can lead to a decrease in the functional activity of proteins such as D9Ertd402e that are regulated by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK1/2, enzymes upstream of ERK in the MAPK pathway. By inhibiting MEK, PD98059 prevents the activation of ERK, which is necessary for the phosphorylation and subsequent activation of proteins, including D9Ertd402e. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Similar to PD98059, U0126 is also an inhibitor of MEK1/2 in the MAPK pathway, preventing the activation of ERK and thus the phosphorylation and activation of D9Ertd402e. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase within the MAPK pathway. Inhibition of p38 MAP kinase can disrupt stress response signaling that may be involved in the regulation or activity of D9Ertd402e. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that impairs the PI3K/Akt pathway, leading to decreased activation of downstream proteins including D9Ertd402e. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
PP242 is a selective mTOR inhibitor that targets both mTORC1 and mTORC2 complexes. By inhibiting mTOR, PP242 decreases the activity of downstream proteins that are regulated by the mTOR pathway, such as D9Ertd402e. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. By inhibiting JNK, SP600125 can reduce the phosphorylation and activation of transcription factors and other proteins, potentially including D9Ertd402e, which may be regulated by JNK-mediated signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor. It can inhibit the activity of various kinases that phosphorylate and activate proteins, such as D9Ertd402e, thereby inhibiting their function. | ||||||